Name | Fosgonimeton |
CAS number | 2093305-05-4 |
Synonym | Fosgonimeton; ATH1017; TH-1017; TH 1017; NDX1017; NDX 1017; NDX-1017; N-hexanoyl-O-phosphono-L-tyrosyl-N1-(6-amino-6-oxohexyl)-L-isoleucinamide |
Description | Fosgonimeton is a Novel Positive Modulator of the HGF/MET System, Fosgonimeton Promotes Neurotrophic and Procognitive Effects in Models of Dementia. Fosgonimeton attenuates amyloid-beta toxicity in preclinical models of Alzheimer's disease. In vivo, fosgonimeton administration led to functional improvement in an intracerebroventricular Aβ25-35 rat model of AD, as it significantly rescued cognitive function in the passive avoidance test. |
Structure |  |
Molecular Formula | C27H45N4O8P |
Molecular Weight | 584.65 g/mol |
Appearance | Solid powder |
Quality Standard | Enterprise Standard |
Assay | ≥98% |
Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
Storage Condition | Store in cool place. Keep container tightly closed in a dry and well ventilated place. |
Shelf Life | >2 years if stored properly |
Sample package | Aluminium foil bag |
Commercial package | Aluminium Tin, Fiber drum |
Origin | China |
Fosgonimeton is an investigational small molecule prodrug designed to positively modulate the hepatocyte growth factor (HGF) system, an endogenous repair mechanism for a healthy nervous system. It is being explored for its potential to treat neurodegenerative diseases like Alzheimer's, Parkinson's, and dementia with Lewy bodies.
Mechanism of Action
Fosgonimeton is converted into its active metabolite, fosgo-AM (also known as ATH-1001), which crosses the blood-brain barrier and enhances the interaction of HGF with its receptor tyrosine kinase MET. This activation induces downstream signaling through PI3k/Akt and MAPK pathways and augmenting NMDA receptor-mediated long-term potentiation through protein kinase C. By positively modulating the HGF/MET system, fosgonimeton aims to promote neuronal health and function, potentially addressing neurodegeneration in dementia.
Preclinical Studies
Preclinical studies of fosgo-AM have demonstrated neurotrophic and neuroprotective effects in primary rat neurons, reversing scopolamine-induced learning deficits in rats. It has also shown the ability to protect cortical neurons from amyloid-ß-induced toxicity.
Clinical Trials
Fosgonimeton has been evaluated in multiple clinical trials:
Phase 1 Trial: A Phase 1 clinical trial found fosgonimeton to be generally safe and well-tolerated in both healthy volunteers and individuals with Alzheimer's disease. The most common side effects were mild pain and itching at the injection site.
Phase 2 ACT-AD Trial: In the Phase 2 ACT-AD trial, fosgonimeton was well-tolerated, with no serious adverse events reported. However, a higher incidence of mild-to-moderate adverse events, such as injection site reactions, transient eosinophilia, and dizziness, were observed in participants treated with fosgonimeton compared to placebo. AEs led to an overall discontinuation rate of 14.3%.
Phase 2/3 LIFT-AD Trial: Top-line data from the Phase 2/3 LIFT-AD trial showed that fosgonimeton failed to significantly improve cognitive and daily functioning in adults with mild to moderate Alzheimer’s disease, despite being safe and well-tolerated.
Safety and Tolerability
Fosgonimeton has generally been well-tolerated in clinical trials, with a favorable safety profile. The most common side effects are injection site reactions, which are generally mild and resolve on their own. Serious adverse events and deaths were not reported in the ACT-AD trial.
Q1. Can I get a free sample?
We can send you a samll free sample, and you only need to pay for the shipping cost.
Q2. What is the HyperChem payment term?
T/T in advance
LC at sight
DP at sight
Bank transfer
PayPal
Bitcoin...
Q3. What is HyperChem shipment policy?
Our policy is to strive for the quickest shipment time possible.
For ready stock samples, they are usually shipped within 3 working days after payment received.
For non-ready stock, please contact HyperChem sales team to negotiate.
Q4. What is HyperChem shipment term?
By Express
FedEx UPS DHL EMS
Fast: 3-7 days around, high cost, door to door service
By Air
Suitable for more than 50kg
Fast: 3-7 days, hight cost, port to port, professional broker needed
By Sea
Suitable for more than 500kg
Fast: 7-45 days, low cost, port to port, professional broker needed
We will always attempt to utilize the quickest and most affordable way for customers to receive orders. And follow -up with customers via email for all shipment details as well as updated track information until it arrives without damage.
Q5. What HyperChem will provide after shipment?
For sample orders:
After shipment is done, an timely email including:
1. Track details (Fedex /TNT/DHL/EMS Track number)
2. Packaging photo
3. COA, MSDS, etc
4. Dispatch date & Estimated arriving time
5. Shipping invoice
For commercial orders
A full set of shipment documents as well as package photos can be provided in scan-copy and original, to help customers complete the customs clearance process.
Established in 2013, Hyper Chem has exclusive tie-ups with leading manufacturers, supplying raw materials produced in GMP and ISO 9002 certified facilities, and provides high-quality ingredients and raw materials to cater to the requirements of our diverse range of clients.
Among them, our key client industrial sectors around the global are:
Pharmaceuticals
Nutrition Ingredients/ Dietary supplements
Cosmetic Ingredients
Food Ingredients
Veterinary API
Agriculture fertilizer
Custom Synthesis lab supply
HyperChem provides to its wonderful and honorable clients comprehensive purchasing and distribution services which ensure that we are delivering the right generic, raw, or customized product, make sure that we are delivering it at the right time, ensure that it is delivered in the specified amount, and in the right kind of packaging to clients and customers of all types of industries irrespective of their size of operation.
Canada
Australia